Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases.
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001168:Arthritis / Q000201:enzymology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000201:enzymology; D001241:Aspirin / Q000494:pharmacology*; D002403:Cathepsins / Q000032:analysis / Q000494:pharmacology; D003864:Depression, Chemical; D005966:Glucuronidase / Q000378:metabolism; D006046:Gold / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D006867:Hydrolases / Q000378:metabolism*; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology*; D007719:Knee Joint; D008099:Liver / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology*; D010003:Osteoarthritis / Q000201:enzymology; D010653:Phenylbutazone / Q000494:pharmacology*; D010744:Phosphoric Monoester Hydrolases / Q000032:analysis; D011817:Rabbits; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D013582:Synovial Fluid / Q000201:enzymology*
D000893:Anti-Inflammatory Agents; D013438:Sulfhydryl Compounds; D006046:Gold; D006867:Hydrolases; D000135:Acid Phosphatase; D010744:Phosphoric Monoester Hydrolases; D005966:Glucuronidase; D002403:Cathepsins; D010653:Phenylbutazone; D001241:Aspirin; D006854:Hydrocortisone; D007213:Indomethacin